Spero Therapeutics, Inc. (SPRO)

Spero Therapeutics Revenue

Spero Therapeutics had revenue of $5.87M in the quarter ending March 31, 2025, a decrease of -36.61%. This brings the company's revenue in the last twelve months to $44.58M, down -59.83% year-over-year. In the year 2024, Spero Therapeutics had annual revenue of $47.98M, down -53.77%.

• Revenue (ttm): $44.58M
• Revenue Growth: -59.83%
• P/S Ratio: 3.59
• Revenue / Employee: $1,393,250
• Employees: 32
• Market Cap: 164.38M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	47.98M	-55.80M	-53.77%
Dec 31, 2023	103.78M	50.27M	93.95%
Dec 31, 2022	53.51M	35.25M	193.10%
Dec 31, 2021	18.26M	8.93M	95.67%
Dec 31, 2020	9.33M	-8.82M	-48.59%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.